对异形特异性RAS-PI3Kα相互作用的结构见解以及RAS在PI3Kα激活中的作用
Daniel Czyzyk1, Wupeng Yan1,2, Simon Messing1
1NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Nature communications
|January 9, 2025
概括
通过激活PI3K-AKT-mTOR通路,RAS和PI3Kα突变驱动癌症. 这项研究揭示了RAS-PI3Kα相互作用的结构基础,为异型特异性癌症抑制剂提供了标.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 结构生物学是结构生物学.
背景情况:
- 在RAS和PI3Kα中的突变是人类癌症的关键驱动因素.
- RAS-PI3Kα的相互作用对于激活PI3Kα和PI3K-AKT-mTOR通路至关重要.
- 了解这种相互作用对于开发向癌症疗法至关重要.
研究的目的:
- 阐明RAS-PI3Kα相互作用的结构细节.
- 为了识别关键的残留物和接口参与结合.
- 为设计异型特异性PI3Kα抑制剂提供基础.
主要方法:
- 用X射线晶体学来确定KRAS,RRAS2和MRAS与PI3Kα (p110α) 的复杂结构.
- 结构和突变分析以评估结合 afinities 和确定关键残留物.
- 对RAS和PI3K同型相互作用的比较分析.
主要成果:
- 确定了与PI3Kα催化子单元 (p110α) 结合的RAS蛋白 (KRAS,RRAS2,MRAS) 的详细结构.
- 确定了控制RAS-PI3Kα结合亲和力的关键残留物和相互作用接口.
- 与p110α的RAS相互作用局限于RAS结合域,不包括激酶域.
- 揭示了RAS和PI3K相互作用的异型特异性差异.
结论:
- 这项研究为RAS-PI3Kα相互作用提供了关键的结构洞察力,RAS-PI3Kα相互作用是癌症的关键机制.
- 识别的结构特征和异型特异性差异为有针对性的药物设计铺平了道路.
- 这项工作为开发新型PI3Kα异形特异性抑制剂提供了蓝图,以破坏瘤信号传递.
更多相关视频
08:07Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry
Published on: July 26, 2019
8.5K
10:05Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle
Published on: March 5, 2019
6.4K
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
MAPK Signaling Cascades
5.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K
Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
Phosphoinositides and PIPs
8.4K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.4K
